A treatment for patients with mood disorders using n-ethyl-2-(5-fluoro-1H-indol-3-yl)-n-methylethan-1-amine or a pharmaceutically acceptable salt thereof

Abstract

The present description relates to a method for treating a patient having a mood disorder, comprising administering to a subject in need a pharmaceutical composition comprising a base compound consisting substantially of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine or a pharmaceutically acceptable salt thereof in a specified dosage regimen.